Vystar to Resume Production of Rx3000 UV Light Air Purifiers for Use in Hospitals, Healthcare Facilities

NEXT STORY
Global Sepsis Therapeutics Market Analysis, Trends, and Forecasts, 2018-2024: GIAPREZA – The Only FDA Approved Branded Drug for Sepsis Treatment
PREV STORY
BioAegis Therapeutics Expands Phase 1b/2a Community-Acquired Pneumonia Study to the Republic of Georgia —Successfully Completes Second of Four Dosing Cohorts
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Turning Point Therapeutics to Participate in Upcoming Investor Conferences

author_avatar
NASDAQ Market News

Cyclacel Pharmaceuticals to Release First Quarter 2019 Financial Results

author_avatar
NASDAQ Market News

Adamis Pharmaceuticals Submits Fast Track Application to FDA for Tempol for the Treatment and Prevention of COVID-19

author_avatar
NASDAQ Market News